Trends in Natural Decannulation in Patients with Robin Sequence: A Twenty-five Year Retrospective Review
Annals of Otology, Rhinology & Laryngology · 2024
DOI: 10.1177/00034894231187290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2024. Verfasst von Hari N Magge und 9 weiteren Autor:innen. Beteiligte Einrichtung: The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. Hauptthemen laut MEDLINE: Pierre Robin Syndrome, Airway Obstruction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Objective
Robin sequence (RS) consists of micrognathia and glossoptosis that result in upper airway obstruction (UAO). In RS patients who undergo tracheostomy, long-term goals include natural decannulation (ND) without further surgical airway intervention. The objective of this study was to identify long-term trends in the rate and length of time to ND.
Methods
Retrospective chart review on 144 patients with RS treated from 1995 to 2020 at a pediatric tertiary care center. Patients were grouped by year of tracheostomy. Demographic data, UAO management, postoperative care, complications, and time to decannulation were recorded.
Results
Thirty-six patients met the inclusion criteria. Tracheostomy was performed at a median age of 45.5 days. 19 (53%) patients experienced ND at a median time of 66.1 months. ND rate was higher in non-syndromic patients (93% non-syndromic vs 27% syndromic; P < .0001) and during the first study period (1995-2006: 78%, 2007-2020: 28%; P = .003). Cox proportional-hazard regression demonstrated that white race [aHR 0.15 (0.03-0.8); P = .023] and higher birthweight [aHR 0.9 (0.8-0.98); P = .018] were associated with a higher likelihood of ND while a syndromic diagnosis had a negative association with ND [aHR 12.5 (3.3-50.0); P < .001].
Conclusions
Our study documented that ND in patients with RS who underwent tracheostomy was significantly associated with ethnicity, birthweight, and syndromic status. The negative impact on successful ND was most observed in patients with syndromic associations. Additionally, ND rates are lower in the 2007 to 2020 subgroup. We suspect this is because alternative management techniques such as tongue lip adhesion and mandibular distraction osteogenesis became primary surgical treatment in severe RS upper airway obstruction at our institution starting in 2007.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Division of Otolaryngology, Children's National Hospital, Washington, DC, USA.
- Division of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, DC, USA.
- Division of Surgery, Children's National Hospital, Washington, DC, USA.
ORCID-Profile: Hari N Magge, Hengameh K Behzadpour, Md Sohel Rana
Zitieren
APA
Magge, H. N., Schild, S. D., Mantilla-Rivas, E., Landry, E. C., Afsar, N. M., Behzadpour, H. K., Manrique, M., Rana, M. S., Oh, A. K., & Reilly, B. K. (2024). Trends in Natural Decannulation in Patients with Robin Sequence: A Twenty-five Year Retrospective Review. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894231187290
Vancouver
Magge HN, Schild SD, Mantilla-Rivas E, Landry EC, Afsar NM, Behzadpour HK, et al. Trends in Natural Decannulation in Patients with Robin Sequence: A Twenty-five Year Retrospective Review. Annals of Otology, Rhinology & Laryngology. 2024. doi:10.1177/00034894231187290
BibTeX
@article{Magge2024,
author = {Magge, Hari N and Schild, Sam D and Mantilla-Rivas, Esperanza and Landry, Evie C and Afsar, Nina M and Behzadpour, Hengameh K and Manrique, Monica and Rana, Md Sohel and Oh, Albert K and Reilly, Brian K},
title = {Trends in Natural Decannulation in Patients with Robin Sequence: A Twenty-five Year Retrospective Review},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2024},
doi = {10.1177/00034894231187290}
}
EUVIMED